Table 3.
Comparison of general demographic data after PSM in subjects with first-episode schizophrenia and clinically stable schizophrenia.
| After PSM |
z/χ2 | P | ||
|---|---|---|---|---|
| FES |
CSS |
|||
| n = 40 | n = 40 | |||
| Age (yrs) | 22 (18.25, 28) | 22 (19, 29.50) | −0.150 | 0.881 |
| Gender | ||||
| Male | 20 (50.0%) | 23 (57.5%) | 0.453 | 0.501 |
| Female | 20 (50.0%) | 17 (42.5%) | ||
| Education (yrs) | 12 (12, 15) | 12 (9.75, 15.75) | −0.050 | 0.960 |
| Smoker (%) | 7 (17.5%) | 7 (17.5%) | 0.000 | 1.000 |
| Alcohol drinker (%) | 2 (5.0%) | 4 (10.0%) | 0.180 | 0.671 |
| Exercise (%) | 10 (25.0%) | 18 (45.0%) | 3.516 | 0.061 |
| Drug dose (DDD) | 346.93 (221.72, 590.63) | 304.19 (150.00, 547.50) | −0.664 | 0.507 |
| Disease course (m) | 2 (1, 6) | 57 (36, 93) | −7.369 | <0.001 |
| BPRS total score | 40 (36.5, 46) | 29.50 (24, 34.50) | −5.005 | <0.001 |
DDD is the average daily chlorpromazine equivalent mg/d.